Testosterone Heart Risk in Men Increases 29 Percent, Says Study

Wednesday, 06 Nov 2013 06:52 AM

By Michael Mullins

  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
Testosterone drugs and heart risk are linked according to a new study published Tuesday in the Journal of the American Medical Association. The study found that testosterone replacement drugs increased a man's odds of having a heart attack, stroke or dying by 29 percent.

In particular, testosterone drugs were linked to atherosclerosis and coronary plaque, and found to worsen sleep apnea – a sleep disorder characterized by shallow or infrequent breathing during sleep, Bloomberg News reported.

Considering the study's findings, Anne Cappola, an associate editor for the Journal of the American Medical Association, advised men to discuss their concerns with their physician and be cautious when considering taking testosterone replacement drugs.

Editor's Note: ObamaCare Is Here. Are You Prepared?

Some "think it’s the fountain of youth," Cappola told Bloomberg News in a telephone interview. "It’s going to give them back sexual performance, strength and endurance. The direct marketing of testosterone is playing into that. There needs to be that other voice saying there’s no medication out there with all benefit and no risk. There’s always a trade-off."

The study was aimed at older men, considering that most who take testosterone replacement drugs are near or approaching the twilight of their life.

Researchers based their findings on 8,709 men treated in the U.S. Veterans Affairs health system, who on average were 60 years or older and many had preexisting health problems, including diabetes, high blood pressure, and blocked heart arteries, the New York Daily News reported.

Being that the study was based on older individuals largely with preexisting conditions, it is unclear what if any affects the drugs would have on healthier, younger men researchers admitted.

"It does kind of raise the question of, maybe when patients and their physicians are thinking about starting testosterone therapy, potential risks such as the ones we looked at should be in that discussion," Dr. P. Michael Ho told the New York Daily News.

Ho worked on the study at Denver's VA Eastern Colorado Health Care System.

Editor's Note: Do You Support Obamacare? Vote in Urgent National Poll

The testosterone replacement drug industry is a $1.6 billion market and growing.

According to the study's authors, testosterone supplement prescriptions have risen five-fold between 2000 and 2011, with more than 5.3 million men using such drugs as of 2011.

Related Stories:

© 2014 Newsmax. All rights reserved.

  Comment  |
   Contact Us  |
  Copy Shortlink
Send me more news as it happens.
Get me on The Wire
Send me more news as it happens.
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Zip Code:
Privacy: We never share your email.
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
You May Also Like

President Erdogan of Turkey Says Women Are Not Equal to Men

Monday, 24 Nov 2014 16:39 PM

Turkey's President Recip Tayyip Erdogan told women at a conference Monday that they can never be equal to men, and that  . . .

Arson Fire? Poland's 750-Year-Old Tree 'Grandpa' Damaged by Flames

Monday, 24 Nov 2014 15:56 PM

A 750-year-old tree in Poland, believed to be the oldest in the country, was damaged by a suspected arson fire last week . . .

Amazon Black Friday Deals Extend for a Week Before Big Shopping Day

Monday, 24 Nov 2014 13:56 PM

Amazon's Black Friday sales started a week early this past Friday, with the Internet retailer posting new deals every 10 . . .

Top Stories

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved